Treatment Action Group releases an updated Information note providing details on the new 0.15% fair share funding targets for TB research.
In 2017, Treatment Action Group (TAG) and partners introduced the 'fair share' funding targets for TB research. The fair share targets called for each country to spend at least 0.1% of its overall research and development (R&D) expenditures on TB R&D in order to meet global TB research funding goals set by the Stop TB Partnership and endorsed by United Nations member states.
Six years on, it is time to refresh the fair share targets to reflect current TB research funding needs and changes in country R&D capacity and spending. TAG released an Information note providing details on the new 0.15% fair share targets and the methodology and sources of data behind them. Structured as a series of 12 questions/answers, the document is intended to be used as reference by advocacy partners and can be cited by partners when using the fair share targets to raise global and national funding for TB R&D.
Download the Information note here.
Source: Treatment Action Group